Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nora Therapeutics Inc.
DescriptionRecombinant human granulocyte colony-stimulating factor (G-CSF; CSF3)
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationInfertility
Indication DetailsImprove in vitro fertilization (IVF) outcomes in women with recurrent pregnancy loss (RPL); Increase success rates of in vitro fertilization (IVF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today